uterine bleeding


Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to uterine bleeding: dysfunctional uterine bleeding

uterine bleeding

Etymology: L, uterus + ME, blod
any loss of blood from the uterus.

uterine bleeding

Bleeding from the uterus. Physiological bleeding via the vagina occurs in normal menstruation. Abnormal forms include excessive menstrual flow (hypermenorrhea, menorrhagia) or too frequent menstruation (polymenorrhea). Nonmenstrual bleeding is called metrorrhagia. Pseudomenstrual or withdrawal bleeding may occur following estrogen therapy. Breakthrough bleeding is the term used for intermenstrual bleeding that sometimes occurs in women who take progestational agents such as birth control pills or receive estrogen-progesterone replacement therapy.
amenorrhea; dysfunctional uterine bleeding; menstruation;
See also: bleeding
References in periodicals archive ?
Abnormal uterine bleeding (AUB) is bleeding that is not part of a woman's normal menstrual cycle.
Uterine bleeding was controlled in 91% of the women receiving ulipristal acetate 5 mg and in 92% of those receiving ulipristal acetate 10 mg, and 19% of those receiving placebo (P<0.
Value of sonohysterography in the diagnosis and management of abnormal uterine bleeding.
Clinical manifestations and treatment of dysfunctional uterine bleeding.
Key Words: uterine bleeding, anovulation, menorrhagia, oligomenorrhea
Hydroxyprogesterone (injected); marketed under the names Gesterol LA 250, Hy/Gestrone, Hylutin, Prodrox and Pro-Span; prescribed for abnormal uterine bleeding, amenorrhea and readying the uterus for menstruation.
Its sole product is the Hydro ThermAblator, or HTA, a proprietary system intended to treat menorrhagia, or dysfunctional uterine bleeding, due to benign causes.
Thus it is not surprising that prolonged uterine bleeding is widely experienced by women who undergo RU486 abortions.
Also, the levonorgestrel IUD, "a highly effective, cost-saving intervention for women with acute uterine bleeding and pelvic pain, was considered [in] only 12%" of the Michigan cases.
Uterine bleeding was controlled in 91% of the women receiving ulipristal acetate 5 mg, 92% of those receiving ulipristal acetate 10 mg and 19% of those receiving placebo (P<0.
Munro (obstetrics and gynecology, UCLA) provides gynecologists, primary doctors, and family planning doctors with an evidence-based context for understanding and managing abnormal uterine bleeding.
Abnormal Uterine Bleeding Therapy Area Pipeline Report